Staar Surgical STAA shares are trading higher on Monday after Sidoti & Co upgraded the stock from Neutral to Buy and announced a price target of $58 per share.
Staar Surgical is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.
Staar Surgical shares were trading up 3% at $47.02 on Monday at the time of publication. The stock has a 52-week high of $62.51 and 52-week low of $23.20.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
